AImmuneLink Co., Ltd. is a biotechnology and digital healthcare company developing CyTOF-based single-cell precision immunoprofiling and AI-driven immunome analytics technologies. Our platform simultaneously analyzes more than 40?50 immune markers from a single sample, enabling high-dimensional characterization of T cells and NK cells, including activation, memory, exhaustion, immune checkpoints, and functional immune responses. We currently provide Lab-CRO services for pharmaceutical and biotechnology companies to support immune response assessment, mechanism-of-action studies, and exploratory biomarker discovery for drug and vaccine development. In the long term, AImmuneLink aims to integrate accumulated immunome data with clinical information and AI-based predictive models to build an Immune Digital Twin platform capable of predicting individual immune status and treatment response.